These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 29947075)

  • 41. Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis.
    Moghadam-Kia S; Oddis CV; Sato S; Kuwana M; Aggarwal R
    Arthritis Care Res (Hoboken); 2016 May; 68(5):689-94. PubMed ID: 26414240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased Serum B Cell Activating Factor and a Proliferation-inducing Ligand Are Associated with Interstitial Lung Disease in Patients with Juvenile Dermatomyositis.
    Kobayashi N; Kobayashi I; Mori M; Sato S; Iwata N; Shigemura T; Agematsu K; Yokota S; Koike K
    J Rheumatol; 2015 Dec; 42(12):2412-8. PubMed ID: 26472413
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical significance of myositis-specific autoantibody profiles in Japanese patients with polymyositis/dermatomyositis.
    Temmoku J; Sato S; Fujita Y; Asano T; Suzuki E; Kanno T; Furuya MY; Matsuoka N; Kobayashi H; Watanabe H; Koga T; Shimizu T; Kawakami A; Migita K
    Medicine (Baltimore); 2019 May; 98(20):e15578. PubMed ID: 31096460
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-Ro52 antibody is an independent risk factor for interstitial lung disease in dermatomyositis.
    Xing X; Li A; Li C
    Respir Med; 2020 Oct; 172():106134. PubMed ID: 32905890
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Splicing factor proline/glutamine-rich is a novel autoantigen of dermatomyositis and associated with anti-melanoma differentiation-associated gene 5 antibody.
    Hosono Y; Nakashima R; Serada S; Murakami K; Imura Y; Yoshifuji H; Ohmura K; Naka T; Mimori T
    J Autoimmun; 2017 Feb; 77():116-122. PubMed ID: 27919567
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Two cases with autoantibodies to small ubiquitin-like modifier activating enzyme: A potential unique subset of dermatomyositis-associated interstitial lung disease.
    Gono T; Tanino Y; Nishikawa A; Kawamata T; Hirai K; Okazaki Y; Shibata Y; Kuwana M
    Int J Rheum Dis; 2019 Aug; 22(8):1582-1586. PubMed ID: 31050194
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma-Derived Exosomal hsa-miR-4488 and hsa-miR-1228-5p: Novel Biomarkers for Dermatomyositis-Associated Interstitial Lung Disease with Anti-Melanoma Differentiation-Associated Protein 5 Antibody-Positive Subset.
    Zhong D; Wu C; Xu D; Bai J; Wang Q; Zeng X
    Biomed Res Int; 2021; 2021():6676107. PubMed ID: 34368354
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease.
    Nishina N; Sato S; Masui K; Gono T; Kuwana M
    RMD Open; 2020 Jun; 6(2):. PubMed ID: 32506053
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis.
    Ceribelli A; Fredi M; Taraborelli M; Cavazzana I; Tincani A; Selmi C; Chan JY; Chan EK; Satoh M; Franceschini F
    Clin Exp Rheumatol; 2014; 32(6):891-7. PubMed ID: 25151986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of anti-melanoma differentiation-associated gene 5 antibody in Hong Kong Chinese patients with idiopathic inflammatory myopathies: diagnostic utility and clinical correlations.
    So H; Ip RW; Wong VT; Yip RM
    Int J Rheum Dis; 2018 May; 21(5):1076-1081. PubMed ID: 29380533
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early initiation of plasma exchange therapy for a patient with anti-MDA5 autoantibody-positive dermatomyositis developing rapidly progressive interstitial lung disease.
    Sasaki N; Ishii A; Kurabayashi T; Sugiyama M; Izumi Y; Nakagome Y; Hirano K; Sasaki S; Kondo Y; Nogi S; Nishikawa A; Hosono Y; Yamada C; Sato S
    Mod Rheumatol Case Rep; 2021 Jan; 5(1):87-94. PubMed ID: 33048020
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MDA5 expression is associated with TGF-β-induced fibrosis: potential mechanism of interstitial lung disease in anti-MDA5 dermatomyositis.
    Shen N; Zhou X; Jin X; Lu C; Hu X; Zhang Y; Jiang Y; Xu Q; Xu X; Liu M; Lu L; Han Y
    Rheumatology (Oxford); 2022 Dec; 62(1):373-383. PubMed ID: 35412608
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dysregulation of the type I interferon system in adult-onset clinically amyopathic dermatomyositis has a potential contribution to the development of interstitial lung disease.
    Sun WC; Sun YC; Lin H; Yan B; Shi GX
    Br J Dermatol; 2012 Dec; 167(6):1236-44. PubMed ID: 23013528
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic evaluation of serum osteopontin in patients with anti-MDA5 antibody-positive dermatomyositis associated interstitial lung disease.
    Gao Y; Zhao Q; Xie M; Yan X; Li Y; Zhang X; Wu H; Dai J; Cao M; Cai H
    Cytokine; 2020 Nov; 135():155209. PubMed ID: 32738770
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
    Yamaguchi K; Yamaguchi A; Kashiwagi C; Sawada Y; Taguchi K; Umetsu K; Oshima K; Uchida M; Suzuki M; Kono S; Takemura M; Masubuchi H; Kitahara S; Hara K; Maeno T; Motegi SI; Muro Y; Sakairi T; Hisada T; Kurabayashi M
    Respir Med; 2018 Jul; 140():1-5. PubMed ID: 29957268
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-MDA5 autoantibodies associated with juvenile dermatomyositis constitute a distinct phenotype in North America.
    Mamyrova G; Kishi T; Shi M; Targoff IN; Huber AM; Curiel RV; Miller FW; Rider LG;
    Rheumatology (Oxford); 2021 Apr; 60(4):1839-1849. PubMed ID: 33140079
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease.
    Gono T; Kaneko H; Kawaguchi Y; Hanaoka M; Kataoka S; Kuwana M; Takagi K; Ichida H; Katsumata Y; Ota Y; Kawasumi H; Yamanaka H
    Rheumatology (Oxford); 2014 Dec; 53(12):2196-203. PubMed ID: 24970922
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dermatomyositis With or Without Anti-Melanoma Differentiation-Associated Gene 5 Antibodies: Common Interferon Signature but Distinct NOS2 Expression.
    Allenbach Y; Leroux G; Suárez-Calvet X; Preusse C; Gallardo E; Hervier B; Rigolet A; Hie M; Pehl D; Limal N; Hufnagl P; Zerbe N; Meyer A; Aouizerate J; Uzunhan Y; Maisonobe T; Goebel HH; Benveniste O; Stenzel W;
    Am J Pathol; 2016 Mar; 186(3):691-700. PubMed ID: 26806087
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical significance and new detection system of autoantibodies in myositis with interstitial lung disease.
    Nakashima R; Hosono Y; Mimori T
    Lupus; 2016 Jul; 25(8):925-33. PubMed ID: 27252271
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation between B-cell epitope profile and clinical features of anti-MDA5 antibody-positive dermatomyositis.
    Yamaguchi K; Poland P; Bijoy George T; Saygin D; Moghadam-Kia S; Aggarwal R; Oddis CV; Zhu L; Ascherman DP
    Rheumatology (Oxford); 2024 Jul; 63(7):2016-2023. PubMed ID: 37815819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.